From Nasdaq.:

Rep. Earl Blumenauer is challenging the DEA on its slow response to cannabis rescheduling. He called for full descheduling of cannabis, criticized current regulations as “arcane,” and demanded transparency. He addressed a letter to the DEA, HHS Secretary Xavier Becerra, and U.S. Attorney General Merrick Garland, expressing frustration.
Blumenauer sought answers on DEA’s timeline for publishing marijuana’s draft rule, standard drug scheduling reviews, and DEA’s consideration of state laws in its decision. The letter reflects growing impatience over the DEA’s review process and emphasizes the need for reform. Blumenauer urged the DEA to prioritize public safety over criminalization and work transparently with Congress.



Read more: Congressman Presses DEA For Action On Cannabis Scheduling Review, Calls Current Situation ‘Arcane And Out-Of-Touch’